Fundraising FoxSinntaxis
Lund, SE · 1 known investors
Find your way into Sinntaxis
Sign up to see every warm intro you have to Sinntaxis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sinntaxis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sinntaxis is a pharmaceutical company developing mGluR5 negative allosteric modulators as a drug therapy to restore brain function and support recovery after stroke and brain injury. Spun out of Lund University, it runs a preclinical discovery platform for stroke recovery research and licensed IP on this treatment approach.
Founders & leadership
TW
Tadeusz WielochFounder & CEO
Investors · 1
Frequently asked questions
- What does Sinntaxis do?
- Sinntaxis is a pharmaceutical company developing mGluR5 negative allosteric modulators as a drug therapy to restore brain function and support recovery after stroke and brain injury. Spun out of Lund University, it runs a preclinical discovery platform for stroke recovery research and licensed IP on this treatment approach.
- Who founded Sinntaxis?
- Sinntaxis was founded by Tadeusz Wieloch.
- Who are Sinntaxis's investors?
- Sinntaxis's investors include LU Innovation.
- Where is Sinntaxis headquartered?
- Sinntaxis is headquartered in Lund, SE.